Snapshots

Search

Search managers or tickers

CRNX Crinetics Pharmaceuticals In

held 1.0 yr · 4 quarters on record · no longer held CRNX across all managers
Position over time
PeriodShares% of portfolioActivityValue
Q4 2024 122,700 0.18% Reduce 60.3% $6M
Q3 2024 309,000 0.55% $16M
Q2 2024 309,000 0.49% $14M
Q1 2024 309,000 0.39% NEW $14M